 | ADMA Biologics Inc | |||
| NGM : ADMA || Location: United States | ||||
$6.27+0.07 (+1.13%) |
3.24 M | 6.1 - 6.29 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 7.293 M |
| March 15, 2024 | 7.994 M |
| Feb. 29, 2024 | 6.725 M |
| Feb. 15, 2024 | 6.151 M |
| Jan. 31, 2024 | 6.840 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.03 | -0.08 | -413.73% |
| 09/30/2023 | -0.01 | 0.01 | 229.87% |
| 06/30/2023 | -0.03 | -0.03 | -17.65% |
| 03/31/2023 | -0.04 | -0.03 | 30.88% |
| 12/31/2022 | -0.06 | -0.06 | 5.96% |
ADMA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 228.220M | Shares Float | 223.715M |
| Short Float | 7.293M | Market Cap | 1414.96M |
| Institution ownership | 77.40% | Insider ownership | 2.626% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.13 | Forward EPS | 0.50 |